No Data
No Data
Anavex Life Sciences Corp. (NASDAQ:AVXL): Is Breakeven Near?
Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024
Buy Rating on Anavex Life Sciences Amid Anticipated European Approval and Market Opportunity for Alzheimer's Drug Blarcamesine
Anavex Life Sciences | 10-Q: Q3 2024 Earnings Report
Express News | Anavex Life Sciences Shares Are Trading Higher After the Company Reported Better-than-expected Q3 EPS Results
JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15
No Data
No Data